Literature DB >> 20730310

The surface electromyography analysis of the non-plegic upper limb of hemiplegic subjects.

Heloyse U Kuriki1, Raquel N de Azevedo, Augusto C de Carvalho, Fábio Mícolis de Azevedo, Rúben F Negrão-Filho, Neri Alves.   

Abstract

Many authors have studied physical and functional changes in individuals post-stroke, but there are few studies that assess changes in the non-plegic side of hemiplegic subjects. This study aimed to compare the electromyographic activity in the forearm muscles of spastic patients and clinically healthy individuals, to determine if there is difference between the non-plegic side of hemiplegics and the dominant member of normal individuals. 22 hemiplegic subjects and 15 clinically healthy subjects were submitted to electromyography of the flexor and extensor carpi ulnaris muscles during wrist flexion and extension. The flexor muscles activation of stroke group (average 464.6 u.n) was significantly higher than the same muscles in control group (mean: 106.3 u.n.) during the wrist flexion, what shows that the non affected side does not present activation in the standard of normality found in the control group.

Entities:  

Mesh:

Year:  2010        PMID: 20730310     DOI: 10.1590/s0004-282x2010000400016

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  2 in total

1.  Extracorporeal Shock Wave Stimulation as Alternative Treatment Modality for Wrist and Fingers Spasticity in Poststroke Patients: A Prospective, Open-Label, Preliminary Clinical Trial.

Authors:  Robert Dymarek; Jakub Taradaj; Joanna Rosińczuk
Journal:  Evid Based Complement Alternat Med       Date:  2016-07-18       Impact factor: 2.629

2.  A randomized controlled trial on the effects induced by robot-assisted and usual-care rehabilitation on upper limb muscle synergies in post-stroke subjects.

Authors:  T Lencioni; L Fornia; T Bowman; A Marzegan; A Caronni; A Turolla; J Jonsdottir; I Carpinella; M Ferrarin
Journal:  Sci Rep       Date:  2021-03-05       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.